
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ATP Synthase Subunits (ATP5E, ATP5L, ATP5I, ATP5D, ATP5G2, ATP5G1, ATP5J, ATP5H, ATP5O, ATP5G3, ATP5J2, ATP5B, ATP5A1, ATP5C1, ATP5F1):** These genes encode subunits of ATP synthase, a critical enzyme in the mitochondrial electron transport chain responsible for ATP production. High expression of these genes suggests a high metabolic activity, often seen in cells with high energy demands.<br>- **COL1A1, COL1A2, COL3A1, DCN:** These genes are associated with extracellular matrix (ECM) components. Collagen genes (COL1A1, COL1A2, COL3A1) are involved in the structural integrity of tissues, while Decorin (DCN) is a small leucine-rich proteoglycan involved in collagen fibrillogenesis.<br>- **IGFBP4:** Insulin-like growth factor binding protein 4 modulates IGF signaling, which can influence cell growth and differentiation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **COL1A1, COL1A2, COL3A1, DCN:** These markers are typically associated with fibroblasts, which are responsible for producing and remodeling the ECM.<br>- **PTRF (Cavin-1):** Known to be involved in caveolae formation and is often expressed in adipocytes and fibroblasts.<br>- **SEPP1 (Selenoprotein P):** Involved in selenium transport and antioxidant defense, often expressed in liver and other tissues but can be present in fibroblasts.<br>- **LHFP (Lipoma HMGIC Fusion Partner):** While not a classical marker, it has been associated with lipomas and may be expressed in mesenchymal cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:<br>- **Fibroblasts:** High expression of collagen genes (COL1A1, COL1A2, COL3A1) and DCN is consistent with fibroblast identity.<br>- **Adipocytes:** PTRF expression is noted in adipocytes, but the lack of other adipocyte-specific markers makes this less likely.<br>- **Myofibroblasts:** A subtype of fibroblasts that express collagen genes and are involved in wound healing and fibrosis.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of collagen genes, DCN, and other ECM-related markers, the most probable general cell type is **fibroblasts**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Myofibroblasts:** Given the high expression of ECM components and potential involvement in tissue remodeling, myofibroblasts are the most likely subtype.<br>2. **Cancer-associated fibroblasts (CAFs):** In the context of breast cancer tissue, fibroblasts can differentiate into CAFs, which support tumor growth and metastasis.<br>3. **Adipocyte-like fibroblasts:** Due to the presence of PTRF, there is a possibility of a fibroblast subtype with adipogenic potential, although this is less likely without additional adipocyte markers.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of fibroblasts, with a high probability of being myofibroblasts. These cells are characterized by the expression of collagen genes and other ECM components, indicating their role in tissue structure and remodeling. In the context of cancer, these fibroblasts may also represent cancer-associated fibroblasts, which play a crucial role in the tumor microenvironment.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    To validate the annotation result, let's follow the outlined steps:<br><br>### Step 1: Marker Consistency<br>- **Markers in the Provided List:** The key functional markers and cell type markers mentioned in the annotation (ATP synthase subunits, COL1A1, COL1A2, COL3A1, DCN, IGFBP4, PTRF, SEPP1, LHFP) are present in the provided marker list.<br>- **Consistency with Identified Cell Type:** The markers COL1A1, COL1A2, COL3A1, and DCN are consistent with fibroblast identity, as these are well-known markers for fibroblasts involved in ECM production and remodeling.<br><br>### Step 2: Mixed Cell Type Consideration<br>- **Potential Mixed Cell Types:** The presence of PTRF and SEPP1 suggests a potential for mixed cell types, such as adipocyte-like fibroblasts or other mesenchymal cells. However, the annotation primarily focuses on fibroblasts, particularly myofibroblasts, which is consistent with the high expression of ECM-related markers.<br>- **High-Ranking Markers:** The high-ranking markers primarily support a fibroblast identity, with a strong emphasis on ECM components. There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided.<br><br>### Conclusion<br>The annotation result is consistent with the provided marker list and the identified cell type. The analysis correctly identifies fibroblasts as the most probable cell type, with a focus on myofibroblasts due to the expression of ECM components. The consideration of potential subtypes, such as cancer-associated fibroblasts and adipocyte-like fibroblasts, is reasonable given the context.<br><br>Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">fibroblasts</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>myofibroblasts</li><li>cancer-associated fibroblasts</li><li>adipocyte-like fibroblasts</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough analysis of the single-cell data, with a focus on identifying the most probable cell types based on the marker list. The strengths of the annotation include:<br><br>1. **Correctness of Annotations**: The identification of fibroblasts as the main cell type is scientifically accurate given the high expression of collagen genes (COL1A1, COL1A2, COL3A1) and DCN, which are well-known markers for fibroblasts involved in ECM production and remodeling. The consideration of myofibroblasts and cancer-associated fibroblasts as subtypes is also appropriate in the context of breast cancer tissue.<br><br>2. **Balanced Consideration of Markers**: The annotation process effectively balances the use of different markers, considering both ATP synthase subunits and ECM-related genes. This approach ensures that the analysis captures both metabolic activity and structural characteristics of the cells.<br><br>3. **Comprehensive View**: The annotation provides a comprehensive view of the cell types present, considering potential subtypes and the context of the tissue origin (breast cancer). The inclusion of possible mixed cell types, such as adipocyte-like fibroblasts, demonstrates an awareness of the complexity of the cell population.<br><br>However, there are some areas for improvement:<br><br>1. **Marker Rank Consideration**: While the annotation considers a wide range of markers, it could place more emphasis on the rank of the markers. For instance, LHFP, which appears first, is not given significant weight in the final annotation. This could be an oversight, as the rank might indicate its importance in the dataset.<br><br>2. **Potential Oversights**: The annotation does not explore the potential significance of other high-ranking markers like PTRF and SEPP1 in detail, which could provide additional insights into the cell population.<br><br>Overall, the annotation is well-executed, with a strong focus on fibroblasts and their subtypes, but could benefit from a more detailed consideration of marker rank and additional high-ranking markers.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    